Rcadia Medical Imaging has been issued a CE Mark for its computer-aided detection software--the COR Analyzer system--that helps identify patients with significant coronary artery disease  by an analysis of coronary CT angiography (CCTA) studies.

The CE Mark will allow the company to market the system in Europe and other countries that accept the CE Mark, said, said the Auburndale, Mass.-based company. The COR Analyzer System is currently marketed in the U.S. and has been cleared by the FDA.